Your browser doesn't support javascript.
loading
Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML.
Batcha, Aarif M N; Buckup, Nele; Bamopoulos, Stefanos A; Jurinovic, Vindi; Rothenberg-Thurley, Maja; Gittinger, Hanna; Ksienzyk, Bianka; Dufour, Annika; Schneider, Stephanie; Kontro, Mika; Saad, Joseph; Heckmann, Caroline A; Sauerland, Cristina; Görlich, Dennis; Berdel, Wolfgang E; Wörmann, Bernhard J; Krug, Utz; Braess, Jan; Mansmann, Ulrich; Hiddemann, Wolfgang; Spiekermann, Karsten; Metzeler, Klaus H; Herold, Tobias.
Afiliação
  • Batcha AMN; Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.
  • Buckup N; Data Integration for Future Medicine (DIFUTURE), LMU Munich, Munich, Germany.
  • Bamopoulos SA; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
  • Jurinovic V; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
  • Rothenberg-Thurley M; Department of Hematology, Oncology and Tumor Immunology (Campus Benjamin Franklin), Charité University Medicine Berlin, Berlin, Germany.
  • Gittinger H; Institute for Medical Information Processing, Biometry and Epidemiology, LMU Munich, Munich, Germany.
  • Ksienzyk B; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
  • Dufour A; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
  • Schneider S; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
  • Kontro M; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
  • Saad J; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
  • Heckmann CA; Department of Medicine III, Laboratory for Leukemia Diagnostics, University Hospital, LMU Munich, Munich, Germany.
  • Sauerland C; Institute of Human Genetics, University Hospital, LMU Munich, Munich, Germany.
  • Görlich D; Department of Haematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Berdel WE; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Wörmann BJ; Foundation for the Finnish Cancer Institute, Helsinki, Finland.
  • Krug U; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Braess J; Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
  • Mansmann U; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Hiddemann W; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Spiekermann K; Department of Medicine A, Hematology and Oncology, University of Münster, Münster, Germany.
  • Metzeler KH; German Society of Hematology and Oncology, Berlin, Germany.
  • Herold T; Department of Medicine III, Hospital Leverkusen, Leverkusen, Germany.
Blood Adv ; 7(6): 1040-1044, 2023 03 28.
Article em En | MEDLINE | ID: mdl-36149944

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Polimorfismo de Nucleotídeo Único Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Polimorfismo de Nucleotídeo Único Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos